Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0016020 | membrane | 2 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: Q4QBG1
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 2 |
GO:0006644 | phospholipid metabolic process | 4 | 2 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 2 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 2 |
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008610 | lipid biosynthetic process | 4 | 2 |
GO:0008654 | phospholipid biosynthetic process | 5 | 2 |
GO:0009058 | biosynthetic process | 2 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0019637 | organophosphate metabolic process | 3 | 2 |
GO:0042592 | homeostatic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044255 | cellular lipid metabolic process | 3 | 2 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 2 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 2 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 2 |
GO:0046486 | glycerolipid metabolic process | 4 | 2 |
GO:0048878 | chemical homeostasis | 4 | 2 |
GO:0055088 | lipid homeostasis | 5 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0065008 | regulation of biological quality | 2 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090407 | organophosphate biosynthetic process | 4 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016746 | acyltransferase activity | 3 | 2 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 2 |
GO:0016787 | hydrolase activity | 2 | 3 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 2 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 2 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 167 | 169 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.702 |
CLV_NRD_NRD_1 | 277 | 279 | PF00675 | 0.541 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.621 |
CLV_NRD_NRD_1 | 4 | 6 | PF00675 | 0.547 |
CLV_PCSK_KEX2_1 | 167 | 169 | PF00082 | 0.402 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.698 |
CLV_PCSK_KEX2_1 | 277 | 279 | PF00082 | 0.541 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.667 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.566 |
CLV_PCSK_PC1ET2_1 | 6 | 8 | PF00082 | 0.474 |
CLV_PCSK_PC7_1 | 24 | 30 | PF00082 | 0.612 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.415 |
CLV_PCSK_SKI1_1 | 250 | 254 | PF00082 | 0.403 |
CLV_PCSK_SKI1_1 | 48 | 52 | PF00082 | 0.479 |
CLV_Separin_Metazoa | 263 | 267 | PF03568 | 0.312 |
DEG_APCC_DBOX_1 | 279 | 287 | PF00400 | 0.345 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.464 |
DOC_CYCLIN_yCln2_LP_2 | 228 | 234 | PF00134 | 0.284 |
DOC_MAPK_gen_1 | 122 | 131 | PF00069 | 0.322 |
DOC_MAPK_gen_1 | 241 | 251 | PF00069 | 0.427 |
DOC_MAPK_gen_1 | 277 | 285 | PF00069 | 0.334 |
DOC_MAPK_gen_1 | 45 | 51 | PF00069 | 0.406 |
DOC_MAPK_MEF2A_6 | 122 | 131 | PF00069 | 0.322 |
DOC_MAPK_MEF2A_6 | 243 | 251 | PF00069 | 0.327 |
DOC_MAPK_MEF2A_6 | 277 | 285 | PF00069 | 0.334 |
DOC_PP1_RVXF_1 | 190 | 196 | PF00149 | 0.310 |
DOC_PP4_FxxP_1 | 157 | 160 | PF00568 | 0.365 |
DOC_PP4_FxxP_1 | 195 | 198 | PF00568 | 0.268 |
DOC_WW_Pin1_4 | 106 | 111 | PF00397 | 0.703 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.494 |
LIG_14-3-3_CanoR_1 | 167 | 176 | PF00244 | 0.417 |
LIG_Actin_RPEL_3 | 234 | 253 | PF02755 | 0.457 |
LIG_Actin_WH2_2 | 252 | 268 | PF00022 | 0.455 |
LIG_BRCT_BRCA1_1 | 143 | 147 | PF00533 | 0.310 |
LIG_CaM_IQ_9 | 38 | 54 | PF13499 | 0.337 |
LIG_FHA_1 | 106 | 112 | PF00498 | 0.762 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.467 |
LIG_LIR_Apic_2 | 194 | 198 | PF02991 | 0.274 |
LIG_LIR_Gen_1 | 144 | 152 | PF02991 | 0.268 |
LIG_LIR_Nem_3 | 144 | 148 | PF02991 | 0.329 |
LIG_LIR_Nem_3 | 205 | 209 | PF02991 | 0.293 |
LIG_LIR_Nem_3 | 229 | 235 | PF02991 | 0.586 |
LIG_NRBOX | 50 | 56 | PF00104 | 0.356 |
LIG_Pex14_2 | 130 | 134 | PF04695 | 0.445 |
LIG_Pex14_2 | 157 | 161 | PF04695 | 0.336 |
LIG_PTB_Apo_2 | 255 | 262 | PF02174 | 0.336 |
LIG_SH2_CRK | 58 | 62 | PF00017 | 0.240 |
LIG_SH2_NCK_1 | 58 | 62 | PF00017 | 0.240 |
LIG_SH2_SRC | 185 | 188 | PF00017 | 0.197 |
LIG_SH2_STAP1 | 33 | 37 | PF00017 | 0.623 |
LIG_SH2_STAP1 | 58 | 62 | PF00017 | 0.240 |
LIG_SH2_STAT5 | 181 | 184 | PF00017 | 0.417 |
LIG_SH2_STAT5 | 185 | 188 | PF00017 | 0.393 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.679 |
LIG_SH3_3 | 267 | 273 | PF00018 | 0.404 |
LIG_SUMO_SIM_anti_2 | 282 | 287 | PF11976 | 0.355 |
LIG_SUMO_SIM_par_1 | 224 | 230 | PF11976 | 0.284 |
LIG_WW_3 | 25 | 29 | PF00397 | 0.608 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.483 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.326 |
MOD_CK1_1 | 95 | 101 | PF00069 | 0.758 |
MOD_CK2_1 | 171 | 177 | PF00069 | 0.355 |
MOD_GlcNHglycan | 88 | 92 | PF01048 | 0.655 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.518 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.392 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.562 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.366 |
MOD_NEK2_2 | 18 | 23 | PF00069 | 0.578 |
MOD_NEK2_2 | 219 | 224 | PF00069 | 0.309 |
MOD_PIKK_1 | 11 | 17 | PF00454 | 0.596 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.661 |
MOD_PKA_1 | 167 | 173 | PF00069 | 0.365 |
MOD_PKA_2 | 167 | 173 | PF00069 | 0.413 |
MOD_Plk_1 | 18 | 24 | PF00069 | 0.638 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.551 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.628 |
MOD_ProDKin_1 | 106 | 112 | PF00069 | 0.700 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.494 |
MOD_SUMO_for_1 | 121 | 124 | PF00179 | 0.432 |
MOD_SUMO_for_1 | 93 | 96 | PF00179 | 0.464 |
TRG_DiLeu_BaEn_1 | 221 | 226 | PF01217 | 0.309 |
TRG_DiLeu_BaEn_1 | 230 | 235 | PF01217 | 0.362 |
TRG_ENDOCYTIC_2 | 33 | 36 | PF00928 | 0.587 |
TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.417 |
TRG_ER_diArg_1 | 22 | 24 | PF00400 | 0.643 |
TRG_ER_diArg_1 | 27 | 29 | PF00400 | 0.557 |
TRG_ER_diArg_1 | 276 | 278 | PF00400 | 0.540 |
TRG_NLS_MonoExtC_3 | 4 | 9 | PF00514 | 0.473 |
TRG_NLS_MonoExtN_4 | 5 | 10 | PF00514 | 0.474 |
TRG_Pf-PMV_PEXEL_1 | 277 | 282 | PF00026 | 0.327 |
TRG_Pf-PMV_PEXEL_1 | 73 | 77 | PF00026 | 0.456 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P520 | Leptomonas seymouri | 52% | 71% |
A0A1X0NG89 | Trypanosomatidae | 34% | 75% |
A0A3S7WXG3 | Leishmania donovani | 83% | 71% |
A0A422NW44 | Trypanosoma rangeli | 39% | 70% |
A4HCM8 | Leishmania braziliensis | 69% | 71% |
A4I052 | Leishmania infantum | 83% | 71% |
E9AW15 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 71% |
V5B077 | Trypanosoma cruzi | 40% | 78% |